Cutler Group LP Curis Inc Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 26, 2021	SELL	$6.94 - $8.85 $172,112 - $219,480	-24,800 Reduced 91.51%	2,300 $0
Q2 2021 Jul 19, 2021	BUY	$7.45 - $16.27 $111,005 - $242,423	14,900 Added 122.13%	27,100 $8,000
Q1 2021 Apr 26, 2021	BUY	$8.78 - $12.8 $81,654 - $119,040	9,300 Added 320.69%	12,200 $10,000
Q4 2020 Jan 21, 2021	BUY	$1.08 - $8.2 $3,132 - $23,779	2,900 New	2,900 $3,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.